Effects of a decision aid for women with BRCA pathogenic variant considering cancer risk management strategies:A Mixed-Methods Study

Effects of a decision aid for women with BRCA pathogenic variant considering cancer risk management strategies:A Mixed-Methods Study - Effects of a decision aid for women with BRCA pathogenic variant considering cancer risk management strategies

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000046942

Enrollment

Registered

2022-05-01

Start date

2022-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary breast and ovarian cancer

Interventions

booklet style decision aid

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 20 years and older women with BRCA pathogenic variant

Exclusion criteria

Exclusion criteria: metastatic cancer patients unable to understand Japanese The physicians in charge judge it difficult for their patients to participate in the program

Design outcomes

Primary

Measure	Time frame
decision conflict scale Preintervention and 4weeks after intervention 7days before and after	—

Countries

Japan

Contacts

Public ContactMegumi Okawa

St' Lukes International Hospital Nursing Department

onmegu@luke.ac.jp03-3541-5151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026